- Home
- HELP vs NVCT Comparison
HELP vs NVCT Comparison
Compare HELP & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HELP | NVCT |
|---|---|---|
| Founded | N/A | 2020 |
| Country | Canada | United States |
| Employees | 50 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.0M | 274.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HELP | NVCT |
|---|---|---|
| Price | $5.03 | $23.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $51.50 | $10.00 |
| AVG Volume (30 Days) | ★ 547.2K | 115.2K |
| Earning Date | 07-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.76 | $5.55 |
| 52 Week High | $8.55 | $18.24 |
Technical Indicators
Market Signals| Indicator | HELP | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 61.20 | 92.81 |
| Support Level | $4.86 | $6.07 |
| Resistance Level | $6.26 | N/A |
| Average True Range (ATR) | 0.31 | 1.46 |
| MACD | 0.12 | 1.23 |
| Stochastic Oscillator | 77.34 | 98.20 |
Price Performance
Historical ComparisonAbout HELP Cybin Inc. Common Stock
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.